Analysis for Tomorrow's Clinical Approach to Diagnostics, Therapy, Intervention and Monitoring Solutions
News Mar 22, 2012
To align the market drivers and restraints into an interpretable roadmap, Frost & Sullivan releases the Advanced MedTech: Enabling Efficient and Outcomes-Oriented Healthcare Delivery, 2010 to 2012 compendium. This resource includes Frost & Sullivan's Advanced Medical Technologies proposed key research for 2012, as well as the profiling of recent content over the last two years.
If you are interested in receiving the complimentary Frost & Sullivan Advanced MedTech: Enabling Efficient and Outcomes-Oriented Healthcare Delivery, 2010 to 2012 compendium,please send an email to Britni Myers, Corporate Communications, at email@example.com, with your full name, company name, job title, telephone number, company email address, company Web site, city, state and country.
Organizations successfully competing in today's healthcare market must consistently review their product and service portfolio to drive value for their partners and clients. Particularly for those companies in the medical technologies space, they must work to outline interweaved opportunities between several key segments, including medical devices, patient monitoring and medical imaging, to discover how they are and can work together. The Frost & Sullivan compendium addresses these vital markets, delineating research that casts light on these shadowy, crossover areas to reveal underlying opportunities.
"Stakeholders in the healthcare ecosystem need to track and benchmark business performance across their core products and solutions portfolios," said Frost & Sullivan Advanced Medical Technologies Global Program Leader Siddharth Saha. "Concurrently, original equipment manufacturer's (OEM's), suppliers and distributors cannot afford to ignore developments in diagnostics, therapeutics and monitoring that can positively or negatively influence the adoption of their core solution."
Frost & Sullivan finds that healthcare solution and service suppliers are increasingly looking to absorb niche technologies into their overall plan. Optimum healthcare delivery must absorb equipment, devices, materials and service lines with the end goal of enhancing outcomes for patients, caregivers and provider organizations in healthcare. This creates implications for product and solution areas, as well as care locations.
"In pursuing their growth objectives, healthcare stakeholders are looking beyond their core customer and target verticals, and actively assessing new geographic markets to open up dialog with complementary solution providers," said Saha. "Synergies in portfolio and business strategies can yield much needed return as suppliers look beyond saturated markets. Tracking the new needs of the ultimate end user in the care pathway, while also understanding the decision making structure, helps make a smoother transition to new business realities."
Shire, Microsoft and EURORDIS Form Global Commission to Accelerate Rare Disease DiagnosisNews
The alliance aims to shorten the often multi-year journey that patients and families endure before being diagnosed with a rare disease.READ MORE
Breast Cancer: How Advanced Imaging Technologies Will Help Avoid Unnecessary BiopsiesNews
Scientists have combined an advanced method of diffusion-weighted MR imaging with intelligent image analysis methods to detect malignant changes in tissues. This method may help avoid many control biopsies following suspicious findings from mammography screening.READ MORE
Liquid Biopsy Can Help Predict Outcomes in Metastatic Triple-Negative Breast CancerNews
A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer.READ MORE